UMIN-CTR Clinical Trial
| Unique ID issued by UMIN | UMIN000025087 |
|---|---|
| Receipt number | R000028620 |
| Scientific Title | The molecular biological characteristic of Solid-pseudopapillary neoplasm of the pancreas |
| Date of disclosure of the study information | 2016/12/01 |
| Last modified on | 2026/01/01 14:10:58 |
* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments
Basic information
Public title
The molecular biological characteristic of Solid-pseudopapillary neoplasm of the pancreas
Acronym
The molecular biological characteristic of Solid-pseudopapillary neoplasm of the pancreas
Scientific Title
The molecular biological characteristic of Solid-pseudopapillary neoplasm of the pancreas
Scientific Title:Acronym
The molecular biological characteristic of Solid-pseudopapillary neoplasm of the pancreas
Region
| Japan |
Condition
Condition
Solid-pseudopapillary neoplasm of the pancreas
Classification by specialty
| Hepato-biliary-pancreatic surgery |
Classification by malignancy
Malignancy
Genomic information
YES
Objectives
Narrative objectives1
To identify the molecular biological characteristic of Solid-pseudopapillary neoplasm of the pancreas.
Basic objectives2
Others
Basic objectives -Others
To identify the relationship between characteristic in molecular biology and clinicopathological findings
Trial characteristics_1
Trial characteristics_2
Developmental phase
Assessment
Primary outcomes
The molecular biological characteristic of Solid-pseudopapillary neoplasm of the pancreas
Key secondary outcomes
The relationship between characteristic in molecular biology and clinicopathological findings
Base
Study type
Observational
Study design
Basic design
Randomization
Randomization unit
Blinding
Control
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment
Intervention
No. of arms
Purpose of intervention
Type of intervention
Interventions/Control_1
Interventions/Control_2
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10
Eligibility
Age-lower limit
| Not applicable |
Age-upper limit
| Not applicable |
Gender
Male and Female
Key inclusion criteria
The patient with histologically confirmed diagnosis of Solid-pseudopapillary neoplasm
Key exclusion criteria
When the patient or his/her family refused to participate in this study
Target sample size
50
Research contact person
Name of lead principal investigator
| 1st name | Yoshihiro |
| Middle name | |
| Last name | Sakamoto |
Organization
Kyorin University,School of Medicine
Division name
Department of Surgery
Zip code
181-8611
Address
6-20-2,Shinkawa,Mitaka-shi,Tokyo,181-8611,Japan
TEL
0422-47-5511
yosakamo@ks.kyorin-u.ac.jp
Public contact
Name of contact person
| 1st name | Kazuna |
| Middle name | |
| Last name | Honda |
Organization
Kyorin University,School of Medicine
Division name
Department of Surgery
Zip code
181-8611
Address
6-20-2,Shinkawa,Mitaka-shi,Tokyo,181-8611,Japan
TEL
0422-47-5511
Homepage URL
khonda@ks.kyorin-u.ac.jp
Sponsor or person
Institute
Kyorin University,School of Medicine
Institute
Department
Personal name
Funding Source
Organization
Kyorin University,School of Medicine
Organization
Division
Category of Funding Organization
Self funding
Nationality of Funding Organization
Other related organizations
Co-sponsor
Name of secondary funder(s)
IRB Contact (For public release)
Organization
Kyorin University School of Medicine
Address
6-20-2,Shinkawa,Mitaka-shi,Tokyo,181-8611,Japan
Tel
0422-47-5511
irb@ks.kyorin-u.ac.jp
Secondary IDs
Secondary IDs
NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW
Institutions
Institutions
Other administrative information
Date of disclosure of the study information
| 2016 | Year | 12 | Month | 01 | Day |
Related information
URL releasing protocol
Publication of results
Unpublished
Result
URL related to results and publications
Number of participants that the trial has enrolled
28
Results
Results date posted
Results Delayed
Results Delay Reason
Date of the first journal publication of results
Baseline Characteristics
Participant flow
Adverse events
Outcome measures
Plan to share IPD
IPD sharing Plan description
Progress
Recruitment status
No longer recruiting
Date of protocol fixation
| 2016 | Year | 07 | Month | 06 | Day |
Date of IRB
| 2016 | Year | 07 | Month | 06 | Day |
Anticipated trial start date
| 2016 | Year | 12 | Month | 20 | Day |
Last follow-up date
| 2026 | Year | 07 | Month | 05 | Day |
Date of closure to data entry
Date trial data considered complete
Date analysis concluded
| 2021 | Year | 12 | Month | 31 | Day |
Other
Other related information
We identify the molecular biological characteristic of Solid-pseudopapillary neoplasm of the pancreas.
Management information
Registered date
| 2016 | Year | 11 | Month | 30 | Day |
Last modified on
| 2026 | Year | 01 | Month | 01 | Day |
Link to view the page
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000028620
